Steven Jacobson

Q: What Schools Are Affiliated With Steven Jacobson

Steven Jacobson is affiliated with the following schools: Université Laval, University of Vermont, Kagoshima University, University of California, Berkeley, Stanford University, Johns Hopkins University

Steven Jacobson's AcademicInfluence.com Rankings

Steven Jacobson

Engineering

#5638

World Rank

#6901

Historical Rank

Electrical Engineering

#1589

World Rank

#1684

Historical Rank

engineering Degrees

Steven Jacobson

Computer Science

#7236

World Rank

#7621

Historical Rank

Computational Linguistics

#1412

World Rank

#1428

Historical Rank

Machine Learning

#2613

World Rank

#2648

Historical Rank

Artificial Intelligence

#2903

World Rank

#2948

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Steven Jacobson's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley
Bachelors Computer Engineering University of California, Berkeley

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026

Why Is Steven Jacobson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Steven Jacobson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease (1990) (616)
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA (1997) (478)
Classification of HHV-6A and HHV-6B as distinct viruses (2014) (266)
Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). (2002) (264)
Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. (1998) (255)
Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker (2010) (247)
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy (2019) (229)
Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis (1988) (228)
Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. (1984) (215)
High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease (1993) (211)
HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells (1989) (197)
Detection of human T‐lymphotropic virus type I (HTLV‐I) tax RNA in the central nervous system of HTLV‐I–associated myelopathy/tropical spastic paraparesis patients by in situ hybridization (1995) (184)
Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections (2003) (182)
Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. (2000) (176)
Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. (1990) (173)
CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. (2001) (164)
Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. (2002) (159)
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. (2016) (158)
Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. (2005) (152)
Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. (1997) (150)
Association of Human Herpesvirus-6B with Mesial Temporal Lobe Epilepsy (2007) (143)
Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. (1999) (142)
Increased HTLV‐I proviral load and preferential expansion of HTLV‐I tax‐specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP (2001) (137)
Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. (2001) (136)
Immunological findings in neurological diseases associated with antibodies to HTLV‐I: Activated lymphocytes in tropical spastic paraparesis (1988) (136)
Free Major Histocompatibility Complex Class I Heavy Chain Is Preferentially Targeted for Degradation by Human T-Cell Leukemia/Lymphotropic Virus Type 1 p12I Protein (2001) (131)
Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients (2000) (129)
Human herpesvirus-6 entry into the central nervous system through the olfactory pathway (2011) (128)
Exosomes in Viral Disease (2016) (127)
High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. (2003) (126)
Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. (1992) (126)
Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. (1998) (122)
Isolation of HTLV‐II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV‐I‐associated myelopathy/tropical spastic paraparesis (1993) (121)
Immunological studies in tropical spastic paraparesis (1990) (115)
Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion (1996) (114)
Human herpes virus 6B: A possible role in epilepsy? (2008) (113)
Abnormally High Levels of Virus-Infected IFN-γ+CCR4+CD4+CD25+ T Cells in a Retrovirus-Associated Neuroinflammatory Disorder (2009) (113)
Translocator Protein PET Imaging for Glial Activation in Multiple Sclerosis (2011) (113)
Human T cell leukemia virus type I and neurologic disease: Events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation (2002) (107)
Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. (1993) (107)
The Immune Response to Viruses (1989) (104)
Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations (2014) (103)
Reducing the global burden of HTLV‐1 infection: An agenda for research and action (2017) (102)
Detection of human herpesvirus‐6 in cerebrospinal fluid of patients with encephalitis (2009) (102)
Increased Expression of Human T Lymphocyte Virus Type I (HTLV-I) Tax11-19 Peptide–Human Histocompatibility Leukocyte Antigen A*201 Complexes on CD4+ CD25+T Cells Detected by Peptide-specific, Major Histocompatibility Complex–restricted Antibodies in Patients with HTLV-I–associated Neurologic Disease (2004) (102)
Viruses and multiple sclerosis. (2012) (101)
Multicenter Comparison of PCR Assays for Detection of Human Herpesvirus 6 DNA in Serum (2008) (101)
Review part 2: Human herpesvirus‐6 in central nervous system diseases (2010) (100)
Evidence linking HHV-6 with multiple sclerosis: an update. (2014) (100)
Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. (2011) (100)
Variant-Specific Tropism of Human Herpesvirus 6 in Human Astrocytes (2005) (99)
HTLV‐I‐specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV‐I‐associated neurological disease (1992) (96)
Quiescent phenotype of tumor-specific CD8+ T cells following immunization. (2004) (94)
Inflammatory manifestations of HTLV-1 and their therapeutic options (2014) (94)
Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis. (2009) (94)
Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. (2007) (93)
Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 Use Different Receptor Complexes To Enter T Cells (2006) (91)
Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease. (2005) (90)
Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes (2005) (88)
Foxp3 Represses Retroviral Transcription by Targeting Both NF-κB and CREB Pathways (2006) (88)
Gene Expression Profile of Herpesvirus-Infected T Cells Obtained Using Immunomicroarrays: Induction of Proinflammatory Mechanisms (2001) (87)
Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. (1999) (86)
HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. (1997) (86)
HTLV-II infection in Florida Indians. (1993) (85)
The formation of inflammatory demyelinated lesions in cerebral white matter (2014) (85)
HTLV-I specific IFN-γ+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals (2000) (84)
Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. (1990) (82)
Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. (2003) (82)
Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. (1997) (80)
HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells. (2014) (80)
CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (2013) (79)
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP. (2011) (77)
Interferon‐β1a therapy in human T‐lymphotropic virus type I–associated neurologic disease (2005) (75)
Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection. (2006) (75)
Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry? (1989) (75)
Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases (2017) (72)
IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients (2001) (71)
Direct Phenotypic Analysis of Human MHC Class I Antigen Presentation: Visualization, Quantitation, and In Situ Detection of Human Viral Epitopes Using Peptide-Specific, MHC-Restricted Human Recombinant Antibodies1 (2003) (69)
Neuroimmunity of HTLV-I Infection (2010) (69)
Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. (2013) (68)
Neuronal molecular mimicry in immune‐mediated neurologic disease (1998) (68)
Correction in trans for Fabry disease: expression, secretion and uptake of alpha-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector. (1996) (68)
Reduction in HTLV‐I proviral load and spontaneous lymphoproliferation in HTLV‐I–associated myelopathy/tropical spastic paraparesis patients treated with humanized anti‐tac (1998) (68)
Impaired measles virus-specific cytotoxic T cell responses in multiple sclerosis (1985) (67)
Human Herpesvirus 6 Detection in Alzheimer’s Disease Cases and Controls across Multiple Cohorts (2020) (67)
Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide–HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections (2003) (64)
Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1. (1991) (64)
In situ analysis of microvascular pericytes in hypertensive rat brains. (1988) (64)
Reactivation of Human Herpesvirus-6 in Natalizumab Treated Multiple Sclerosis Patients (2008) (64)
Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy. (2008) (63)
HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. (2006) (63)
Viral pathogenesis and resistance to defective interfering particles (1980) (60)
Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis (2001) (59)
GLUT1 Is Not the Primary Binding Receptor but Is Associated with Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (2006) (59)
In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells. (2001) (58)
In vivo quantification of T2 ⁎ anisotropy in white matter fibers in marmoset monkeys (2012) (58)
Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors. (1995) (57)
Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study (2020) (56)
Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease (2011) (56)
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization (2013) (55)
Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain. (1988) (55)
Multistability in a Model for CTL Response to HTLV-I Infection and Its Implications to HAM/TSP Development and Prevention (2010) (54)
Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings (2014) (54)
Role of viruses in etiology and pathogenesis of multiple sclerosis (2001) (53)
Coinfection of Human Herpesviruses 6A (HHV-6A) and HHV-6B as Demonstrated by Novel Digital Droplet PCR Assay (2014) (52)
Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP (2017) (52)
Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. (2000) (49)
A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients. (1996) (49)
Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression (2002) (48)
Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I (2007) (47)
Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease. (1996) (47)
Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. (2009) (47)
Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. (2000) (47)
Human T‐cell lymphotropic virus type II–associated myelopathy: Clinical and immunologic profiles (1996) (47)
Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) (2008) (45)
Identification of a specific HLA DR2 Ia molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones (1985) (43)
Human T Cell Leukemia Virus Reactivation with Progression of Adult T-Cell Leukemia-Lymphoma (2009) (42)
Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans (2015) (41)
Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease. (2008) (41)
Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination (2018) (40)
Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis (2005) (39)
Measles virus persistence in human lymphocytes: a role for virus-induced interferon. (1982) (39)
Characterization of microvascular cell cultures from normotensive and hypertensive rat brains: pericyte-endothelial cell interactions in vitro. (1987) (39)
Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. (2005) (39)
Molecular analysis of HTLV-I proviral integration and T cell receptor arrangement indicates that T cells in tropical spastic paraparesis are polyclonal. (1989) (38)
Human Herpesvirus 6 (HHV-6) Induces Dysregulation of Glutamate Uptake and Transporter Expression in Astrocytes (2008) (38)
Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease. (2008) (38)
Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis (2019) (37)
Interferon induction by lymphocytic choriomeningitis viruses correlates with maximum virulence. (1981) (37)
Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy (2001) (37)
Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes (2018) (37)
Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease (2005) (36)
A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design. (2003) (36)
Co-dependence of HTLV-1 p12 and p8 Functions in Virus Persistence (2014) (35)
Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls (2016) (35)
In vivo imaging of spinal cord atrophy in neuroinflammatory diseases (2014) (35)
Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus). (2006) (35)
Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells (1997) (35)
Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis (2018) (34)
Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica. (2012) (34)
Site-specific immune response to implanted gliomas. (2001) (34)
Comprehensive Analysis of TCR-β Repertoire in Patients with Neurological Immune-mediated Disorders (2019) (33)
Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells (1994) (33)
Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients. (2005) (32)
The Prevalence and Significance of HTLV-I/II Seroindeterminate Western Blot Patterns (2011) (32)
Determinants of spontaneous recovery and persistance in MDCK cells infected with lymphocytic choriomeningitis virus. (1979) (32)
Potential role of iron in repair of inflammatory demyelinating lesions. (2019) (32)
Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. (1997) (31)
Extended observations on the association of HHV-6 and multiple sclerosis. (2000) (31)
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis. (1999) (30)
Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients (2013) (30)
High Expression of CD244 and SAP Regulated CD8+ T Cell Responses of Patients with HTLV-I Associated Neurologic Disease (2009) (30)
Differential HHV‐6A gene expression in T cells and primary human astrocytes based on multi‐virus array analysis (2006) (30)
Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations (2004) (29)
TGF-β signaling is altered in the peripheral blood of subjects with multiple sclerosis (2011) (29)
Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient (2011) (27)
Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I. (2006) (27)
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma (2016) (26)
Association of human herpesvirus-6 and multiple sclerosis: here we go again? (1998) (26)
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals (2013) (26)
ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions (1998) (26)
Imaging spinal cord atrophy in progressive myelopathies: HTLV‐I‐associated neurological disease (HAM/TSP) and multiple sclerosis (MS) (2017) (26)
Viral Triggers and Inflammatory Mechanisms in Pediatric Epilepsy (2018) (25)
Etiologies of rash and fever illnesses in Campinas, Brazil. (2011) (25)
Mechanism of Neuroinflammation: Enhanced Cytotoxicity and IL-17 Production via CD46 Binding (2010) (25)
Characterization and Sequencing of Prototypic Human T-Lymphotropic Virus Type 1 (HTLV-1) from an HTLV-1/2 Seroindeterminate Patient (2000) (25)
Impaired human leukocyte antigen–restricted measles virus–specific cytotoxic T‐cell response in subacute sclerosing panencephalitis (1989) (25)
Intrathecal T‐cell clonal expansions in patients with multiple sclerosis (2016) (25)
CD46 on glial cells can function as a receptor for viral glycoprotein‐mediated cell–cell fusion (2005) (25)
Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases (2018) (24)
PCR-in situ hybridization detection of human T-cell lymphotropic virus type 1 (HTLV-1) tax proviral DNA in peripheral blood lymphocytes of patients with HTLV-1-associated neurologic disease (1996) (24)
Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease (2006) (24)
Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease. (1997) (24)
Prediagnostic human T lymphotropic virus type I provirus loads were highest in Jamaican children who developed seborrheic dermatitis and severe anemia. (2004) (24)
Custom fit 3D-printed brain holders for comparison of histology with MRI in marmosets (2016) (23)
Infection with HHV-6 and its role in epilepsy (2019) (23)
Cytotoxic T cells are induced in mice infected with lymphocytic choriomeningitis virus strains of markedly different pathogenicities (1982) (23)
Utilizing 3D Printing Technology to Merge MRI with Histology: A Protocol for Brain Sectioning (2016) (23)
Epigenetic Modification of the FoxP3 TSDR in HAM/TSP Decreases the Functional Suppression of Tregs (2014) (23)
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging (2014) (23)
The Effect of Human β2-Microglobulin on Major Histocompatibility Complex I Peptide Loading and the Engineering of a High Affinity Variant (1998) (23)
Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches. (2004) (23)
Effect of treatment of Strongyloides infection on HTLV‐1 expression in a patient with adult T‐cell leukemia (2007) (23)
Human T lymphotropic virus, type-I myelopathy: an immunopathologically mediated chronic progressive disease of the central nervous system. (1995) (23)
Detection of HHV-6 and EBV and Cytokine Levels in Saliva From Children With Seizures: Results of a Multi-Center Cross-Sectional Study (2018) (22)
Cytokine Therapies in Neurological Disease (2016) (22)
Induction of measles virus-specific human cytotoxic T cells by purified measles virus nucleocapsid and hemagglutinin polypeptides. (1987) (22)
How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy/tropical spastic paraparesis? (2000) (22)
Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion (2019) (21)
Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation (2020) (21)
Human Herpesvirus 6 as a Viral Trigger in Mesial Temporal Lobe Epilepsy. (2015) (20)
Targeting the Binding Interface on a Shared Receptor Subunit of a Cytokine Family Enables the Inhibition of Multiple Member Cytokines with Selectable Target Spectrum* (2015) (20)
Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease (2012) (20)
Cortical neuronal cytoskeletal changes associated with FIV infection. (1997) (20)
Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2019) (19)
Transverse relaxation of cerebrospinal fluid depends on glucose concentration. (2017) (19)
Complete replication cycle and acquisition of tegument in nucleus of human herpesvirus 6A in astrocytes and in T‐cells (2006) (19)
Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica. (2006) (18)
HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease. (1999) (18)
Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease (1995) (18)
Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells (2006) (17)
In vivo immunogenicity of Tax (11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine. (2014) (17)
Purification of infectious human herpesvirus 6A virions and association of host cell proteins (2007) (17)
Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells (2006) (17)
Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysis (2004) (17)
Viruses in chronic progressive neurologic disease (2018) (17)
Recognition of intracellular measles virus antigens by HLA class II-restricted measles virus-specific cytotoxic T lymphocytes (1987) (16)
The “central vein sign” in inflammatory demyelination: The role of fibrillar collagen type I (2019) (16)
Sequence comparisons of HTLV‐I from HAM/TSP patients and their asymptomatic spouses (1993) (16)
Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease. (2011) (15)
An Altered Peptide Ligand Antagonizes Antigen-Specific T Cells of Patients with Human T Lymphotropic Virus Type I-Associated Neurological Disease (2000) (15)
Polypeptide specificities of measles virus-reactive T cell lines and clones derived from a patient with multiple sclerosis. (1986) (15)
Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/tropical spastic paraparesis patients. (1996) (15)
Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization. (2013) (15)
Demonstration of human T‐cell lymphotrophic virus type I (HTLV‐I) from an HTLV‐I seronegative South Indian patient with chronic, progessive spastic paraparesis (1993) (15)
Common γ-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (2015) (14)
Protective Efficacy of Multiepitope Human Leukocyte Antigen–A*0201 Restricted Cytotoxic T-Lymphocyte Peptide Construct Against Challenge With Human T-Cell Lymphotropic Virus Type 1 Tax Recombinant Vaccinia Virus (2004) (14)
Atomic structure of the human herpesvirus 6B capsid and capsid-associated tegument complexes (2019) (14)
HTLV‐I‐Associated Myelopathy/Tropical Spastic Paraparesis: Semiautomatic Quantification of Spinal Cord Atrophy from 3‐Dimensional MR Images (2014) (13)
DNA restriction fragment length polymorphism of HLA-DR2: Correlation with HLA-DR2-associated functions (1986) (13)
GLUT 1 Is Not the Primary Binding Receptor but Is Associated with Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (2007) (13)
Serum proteomic analysis of a pre‐symptomatic multiple sclerosis cohort (2015) (13)
Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome. (2016) (13)
Immunopathogenesis of HTLV-I associated neurologic disease: massive latent HTLV-I infection in bone marrow of HAM/TSP patients. (1997) (13)
Role of Exosomes in Human Retroviral Mediated Disorders (2018) (13)
HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice (2016) (13)
Vaccinations for Neuroinfectious Disease: A Global Health Priority (2016) (12)
Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice (2019) (12)
Pathological and virological assessment of acute HTLV-I-associated myelopathy complicated with encephalopathy and systemic inflammation (2003) (12)
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals (2014) (12)
Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1) (2016) (11)
Recognition of Intracellular Measles Virus Antigens by HLA Class II Restricted Measles Virus‐Specific Cytotoxic T Lymphocytes (1988) (11)
Association of Chlamydia pneumoniae and multiple sclerosis: Stage two? (2001) (11)
Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls (2019) (11)
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study (2021) (11)
Virus‐Specific Cytotoxic T Cells in Multiple Sclerosis (1988) (10)
In Situ PCR for the Detection of HTLV‐I in HAM/TSP Patients (1994) (10)
Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice. (2018) (10)
Haploinsufficiency of immune checkpoint receptor CTLA4 induces a distinct neuroinflammatory disorder. (2020) (10)
Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis (2006) (9)
Major histocompatibility complex molecules as virus receptors. (1984) (9)
Induction of HLA class II in HTLV-I infected neuronal cell lines. (1995) (9)
Highlights from 5th International Conference on HHV-6 and -7. (2006) (9)
Association of chronic progressive neurological disease and ubiquitous viral agents: lessons from human herpesvirus 6 and multiple sclerosis (2002) (9)
Preexisting Infection with Human T-Cell Lymphotropic Virus Type 2 neither Exacerbates nor Attenuates Simian Immunodeficiency Virus SIVmac251 Infection in Macaques (2010) (9)
Cellular and Humoral Immune Responses Associated with HTLV‐I Associated Myelopathy/Tropical Spastic Paraparesis (1997) (9)
Cytotoxic T cells in paramyxovirus infection of humans. (1994) (9)
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases (2022) (9)
Impaired Measles‐Specific Cytotoxic T‐Cell Response in Subacute Sclerosing Panencephalitis (1988) (8)
HHV-6 and the Central Nervous System (2006) (8)
Receptor β IL-2 / 15 R Monoclonal Antibody Directed to the Paraparesis : Implications for Therapy with a I-Associated Myelopathy / Tropical Spastic Human T Lymphotropic Virus Type Involvement of IL-15 in the Pathogenesis of (1999) (8)
Role of Viral Infection in the Aetiology of Multiple Sclerosis (1999) (8)
Immune response to retroviruses in the central nervous system (1992) (8)
Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability (2021) (8)
Reply to “HHV-6 and multiple sclerosis” (1998) (8)
Detection of HHV-6B in post-mortem central nervous system tissue of a post-bone marrow transplant recipient: a multi-virus array analysis (2006) (7)
Hypoxanthine-guanine phosphoribosyltransferase reporter gene mutation for analysis of in vivo clonal amplification in patients with HTLV type 1-associated Myelopathy/Tropical spastic paraparesis. (2000) (7)
Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia (2011) (7)
An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity (2019) (7)
Clinical trial of a humanized anti‐IL‐2/IL‐15 receptor β chain in HAM/TSP (2019) (7)
MEASLES VIRUS INFECTION OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES: IMPORTANCE OF THE OKT4+ T-CELL SUBSET1 (1984) (7)
Epstein-Barr Virus and MS:Causality or Association? (2011) (7)
Viruses and multiple sclerosis. (2012) (7)
Multicenter Comparison of PCR Assays for Detection of Human Herpesvirus 6 DNA in Serum (2009) (6)
The emerging role of HHV-6 in neurologic disease: lesson from multiple sclerosis and epilepsy (2006) (6)
HHV‐6 and hippocampal volume in patients with mesial temporal sclerosis (2020) (6)
Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis (2020) (6)
Natalizumab and immune cells. (2006) (6)
Virus-specific HLA Class II-restricted Cytotoxic T Cells (1986) (6)
The spectrum of spinal cord lesions in a primate model of multiple sclerosis (2020) (6)
Changes in leukocyte recirculation, NK cell activity, and HLA-DR expression in peripheral blood mononuclear cells of MS patients treated with Poly ICLC. (1991) (5)
Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study (2015) (5)
Lymphotropic Virus-Associated Myelopathy Complexes in Patients with Human T Cell with Soluble HLA-A 2 / Tax 11-19 Tetramer T Cells + Direct Analysis of Viral-Specific CD 8 (1999) (5)
Immunopathogenic CSF TCR repertoire signatures in virus-associated neurologic disease (2021) (4)
Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cells. (2009) (4)
Clinical subtype of HAM/TSP based on clinical course and laboratory findings (2011) (4)
Parkinsonism in the course of HTLV‐I‐associated myelopathy (2005) (4)
Using Droplet Digital PCR to Detect Coinfection of Human Herpesviruses 6A and 6B (HHV-6A and HHV-6B) in Clinical Samples. (2018) (4)
Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD (2023) (4)
The contribution of monocytes/macrophages to HTLV-1 infection and persistence (2014) (4)
International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials (2005) (4)
Ultrahigh-resolution MRI Reveals Extensive Cortical Demyelination in a Nonhuman Primate Model of Multiple Sclerosis. (2020) (4)
Detection of Human T-cell Lymphotropic Virus Type I proteins in exosomes from HAM/TSP patient CSF by novel nanotrap technology (I7-5E) (2015) (4)
HPRT mutations, TCR gene rearrangements, and HTLV‐1 integration sites define in vivo T‐cell clonal lineages (2005) (4)
Viral Infections of the Central Nervous System: Pathogenesis to Therapeutics (2010) (4)
Detection of HTLV-I in Peripheral Blood Lymphocytes from Patients with Chronic HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis and Asymptomatic Carriers by PCR-in situ Hybridization. (1997) (3)
Human T-Cell Lymphotropic Virus Type 1 Infection (2013) (3)
Human herpesvirus 6 and epilepsy (2021) (3)
Dynamic acquisition of HTLV-1 tax protein by mononuclear phagocytes: Role in neurologic disease (2017) (3)
Differential activation of neuroinflammatory pathways in children with seizures: A cross-sectional study (2019) (3)
HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs (2014) (3)
Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP (2021) (3)
Regulatory T Cells Are Reduced During Anti-CD 25 Antibody Treatment of Multiple Sclerosis (2009) (3)
Detection of HTLV-1 replication and CD4+ proliferation in the humanized BLT mouse model (2015) (3)
Digital droplet PCR for precise quantification of human T-lymphotropic virus 1 proviral loads (2014) (3)
Virus-Induced Demyelination: The Case for Virus(es) in Multiple Sclerosis (2016) (3)
Erratum to: Translocator Protein PET Imaging for Glial Activation in Multiple Sclerosis (2011) (3)
Virus-specific cytotoxic T lymphocytes in multiple sclerosis: a normal mumps virus response adds support for a distinct impairment in the measles virus response (1989) (3)
Both orf-I isoforms, p12 and p8, are required for efficient HTLV-1 infection and persistence (2014) (3)
Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis (2020) (3)
BNZ-gamma peptide, a potential therapeutic agent in HTLV-1 associated myelopathy (2014) (2)
Animal Models of Alzheimer's Disease Should Be Controlled for Roseolovirus. (2020) (2)
Infection and Multiple Sclerosis (2004) (2)
Summary of the 6th International Conference on HHV-6 and -7. (2008) (2)
Virus-induced CXCL10-CXCR3 positive feedback loop via astrocytes is critical for maintaining chronic inflammatory lesions in HAM/TSP (2014) (2)
Correlation of increased CXCL13 with intrathecal humoral immune responses to HTLV-1 in CSF of patients with HAM/TSP (2014) (2)
Immune Response to HTLV-I and HTLV-II (2001) (2)
The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease (2010) (2)
Atypical human T‐cell lymphotropic virus type‐I‐associated T‐cell lymphoma in a low‐prevalence alaska native population. Implications for Disease Surveillance (1993) (2)
Deep sequencing of the TCRβ repertoire reveals T cell clonal expansion is associated with HTLV-1 proviral load in HAM/TSP patients (2015) (2)
GLUT 1 Is Not The Primary Binding Receptor But Is Associated With Cell-Cell Transmission Of HTLV-1 (2006) (2)
Do herpesviruses play a role in Alzheimer’s disease pathogenesis? (2019) (2)
High Human T Cell Lymphotropic Virus Type 1 (HTLV-1)-specific Precursor Cytotoxic T Lymphocyte Frequencies in Patients with HTLV-l-associated Neurological Disease By Irina Elovaara,* Scott Koenig,~ A. Yambusu Brewah,~ (1993) (2)
A multi-cytokine inhibitory peptide (BNZ 132-1) that is a potential therapeutic agent for HAMTSP and other necrotizing diseases. (2015) (2)
CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (2014) (2)
Opinion and Special Articles: Cerebellar Ataxia and Liver Failure Complicating IPEX Syndrome (2020) (2)
Comprehensive Analysis of TCR-β Repertoire in Patients with Neurological Immune-mediated Disorders (2019) (2)
Human Herpesvirus 6A, 6B, and 7 Encephalitis (2013) (2)
Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1–Associated Neurologic Disease (2021) (2)
68: HHV-6 and mesial temporal lobe epilepsy: detection of viral DNA and antigen in brain tissue primary cultured astrocytes and implication for a viral role in pathogenesis (2006) (2)
Clinical trial of a humanized monoclonal anti-IL15Rβ (CD122), in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP) (2014) (2)
P168 Selective inhibition of multiple cytokines: A novel therapeutic strategy for immune-mediated diseases (2012) (1)
Microenvironment Impacts the Molecular Architecture and Interactivity of Resident Cells in Marmoset Brain (2021) (1)
Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease (2012) (1)
Viral neuropathogenesis (2011) (1)
Reply to Zahednasab et al.: HHV-6 and marmoset EAE (2018) (1)
C2H2-546: a zinc finger protein differentially expressed in HTLV-1 infected T cells. (1997) (1)
Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2019) (1)
Both orf-I isoforms, p12 and p8, are required for efficient HTLV-1 infection and persistence (2014) (1)
Kinetics and intracellular compartmentalization of HTLV-1 gene expression (2011) (1)
Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls (2016) (1)
Mumps virus-specific cytotoxic T lympocyte responses can be mediated by class II MHC-restricted CD4+ cells (1987) (1)
Quantifying spinal cord cross-sectional area in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2014) (1)
T cell receptor repertoire analysis in HTLV-1-associated diseases (2022) (1)
Myelin basic protein specific TCR-engineered regulatory T cells from multiple sclerosis patients are suppressive to MBP-specific T effector cells (2019) (1)
HTLV-1 Tax induces Th1 master regulator T-bet and thus IFN-γ in CD4+CCR4+ T-cells of virus-associated myelopathy patients (2015) (1)
Progressive multifocal leukoencephalopathy lesion and brain parenchymal segmentation from MRI using serial deep convolutional neural networks (2020) (1)
An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity (2019) (1)
Restricted TCR Vα and Vβ usage by HTLV-specific CD8+ CTL from peripheral blood of patients with HAM/TSP (1994) (1)
NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis (2011) (1)
Characterization Of Antigen‐specific T Cells in Multiple Sclerosis Twins with Elevated Responses to Measles Virus (1984) (1)
Quantitative differences in antibody responses between normal donors HAM/TSP patients, asymptomatic carriers, and ATL patients from Jamaica: can they be used to estimate risk of disease? (2011) (1)
Development of HTLV-1 associated myelopathy/tropical spastic paraparesis in a patient with simian T-lymphotropic virus type 1-like infection. (2015) (1)
The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP (2011) (1)
Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP) (2015) (1)
HTLV-I/II (2008) (1)
Introduction to the Special Issue (2005) (1)
Peptide/HLA-GFP Complexes (2005) (1)
Correlation of increased CXCL13 with intrathecal humoral immune responses to HTLV-1 in CSF of patients with HAM/TSP (2014) (1)
HTLV-1 burden dependent on hijacking monocytes chemotaxis (2015) (1)
Human Herpes Virus 6 in human epilepsy: Data from surgical resections (2014) (0)
The repertoire of CSF antiviral antibodies in patients with neuroinflammatory diseases (2023) (0)
ROLE OF HTLV-I SPECIFIC CTL IN HAM/TSP (2003) (0)
Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients (2012) (0)
( Düsseldorf , D ) 15 HTLV-I transcription during cellular differentiation and activation in bone marrow , peripheral blood , and brain (2005) (0)
Role of Exosomes in Human Retroviral Mediated Disorders (2018) (0)
Detection of HTLV-I Tax11-19 peptide/HLA-A*201 complexes are overexpressed in HAM/TSP patients (2003) (0)
58: Efficacy of anti-viral compounds in HHV-6 infected glial cells (2006) (0)
Differential tropism of human herpesvirus 6 variants A and B for primary human glial cells (2003) (0)
Classification of HHV-6A and HHV-6B as distinct viruses (2013) (0)
Clinical trial of a humanized monoclonal anti-IL15Rβ (CD122), in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP) (2014) (0)
Vaccinations for Neuroinfectious Disease: A Global Health Priority (2016) (0)
Concentration dependent inhibitory effect of a nucleoside-based analog, 2,2-bis-hydroxymethyl-cyclopropavir, against human herpesvirus-6 replication (2014) (0)
Patterns of Spinal Cord Atrophy in Neuroinflammatory Diseases (P6.117) (2016) (0)
In Vivo MRI of Endogenous Remyelination in a Nonhuman Primate Model of Multiple Sclerosis (2021) (0)
Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP) (2015) (0)
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial (2023) (0)
A Robust and Fast Algorithm for Quantifying Spinal Cord Cross-sectional Area in Myelitis (P6.136) (2014) (0)
65: Human herpesvirus 6 – an underappreciated pathogen in encephalitis (2006) (0)
AN ALTERED PEPTIDE LIGAND ANTAGONIZES ANTIGEN-SPECIFIC CD8+ CTL IN PERIPHERAL BLOOD OF HAM/TSP PATIENTS (1999) (0)
In vivo immunogenicity of Tax (11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine. (2015) (0)
Development of HTLV-1 associated myelopathy/tropical spastic paraparesis in a patient with simian T-lymphotropic virus type 1-like infection. (2015) (0)
CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (2014) (0)
Quiescent phenotype of tumor-speciﬁc CD8 (cid:1) T cells following immunization (2004) (0)
Highly Precise Quantification of Multiple Human Herpesviruses in Glioblastoma Samples by Droplet Digital PCR (S43.004) (2015) (0)
Nanomedicine in Demyelinating Disease: Application to Diagnosis and Therapy in Multiple Sclerosis (2013) (0)
BNZ-gamma peptide, a potential therapeutic agent in HTLV-1 associated myelopathy (2014) (0)
Diversity and Function of Human Class II MHC Antigens (1988) (0)
Common Sense Paths Follow Brain Injuries (2012) (0)
Cytokine Therapies in Neurological Disease (2016) (0)
IMMUNOLOGY OF NEURODEVELOPMENTAL DISORDERS Association of chronic progressive neurological disease and ubiquitous viral agents: lessons from human herpesvirus 6 and multiple sclerosis (2002) (0)
Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1) (2016) (0)
Correlations of diffusion tensor imaging and clinical measures with spinal cord cross-sectional area measurements in pediatric spinal cord injury patients. (2021) (0)
Viral neuropathogenesis (2002) (0)
HTLV-1 Infected CD4 + CD25 + CCR4 + T-Cells Disregulate Balance of Inflammation and Tolerance in HTLV-1 Associated Neuroinflammatory Disease (2011) (0)
6. PCR analysis for HTLV-I and HTLV-II sequences in patients with multiple sclerosis (1991) (0)
Reviews in NeuroVirology: An introduction (2011) (0)
HHV-6 and Multiple Sclerosis (2014) (0)
Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma (2015) (0)
Detection Paraparesis Patients by Intracellular Cytokine HTLV-I-Associated Myelopathy / Tropical Spastic Lymphocytes Directly in Peripheral Blood of + Type I ( HTLV-I ) Tax-Specific CD 8 Demonstration of Human T Lymphotropic Virus (1998) (0)
Vascular and angiogenic factors in a non-human primate model of Multiple Sclerosis (MS): Human biomarker cross-reactivity with EAE in the common marmoset (S12.004) (2015) (0)
Phenotypic analysis of HTLV-I Tax11-19-specific CD8+ cells (1999) (0)
Association Between Human Herpes Virus 6 And Hippocampal Volume In Mesial Temporal Lobe Epilepsy (I1-2.003) (2014) (0)
Deep sequencing of T-cell receptor repertoire reveals enrichment of highly expanded clonotypes in cerebrospinal fluid from patients with multiple sclerosis (P5.232) (2015) (0)
Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506 ( antiviral agents / AIDS ) (0)
Quiescence of circulating tumor-specific CD8+ T cells following immunization might explain in their coexistence with tumor cells (2003) (0)
Immunopathogenesis of human retroviral associated neurologic disease: Insights into our understanding of multiple sclerosis (1998) (0)
The 8 kD form encoded by the HTLV-1or F-1 is associated with low provirus levels and healthy carrier state in a subset of HTLV-1 infected individuals (2009) (0)
Multiple Cytokine and Chemokine Analysis from Serum and CSF of HAM/TSP Patients and Asymptomatic Carriers by Recycling Immunoaffinity Chromatography. (1999) (0)
Quantitative Detection of Human Herpesvirus-6 with Digital Droplet PCR in a Patient with Post-Transplant HHV-6 Encephalitis (P6.305) (2015) (0)
HUMAN T-CELL LYMPHOTROPIC VIRUS-I TAX PROTEIN TRANSACTIVATES IL-2 AND IL-15 GENE TRANSCRIPTION: PATHOGENIC IMPLICATIONS AND RATIONALE FOR IMMUNOTHERAPY. (1999) (0)
HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs (2014) (0)
Chemokines in chronic progressive neurological associated myelopathy and diseases: mu1 t ip le HTLV-1 sclerosis (1999) (0)
Exosomes in Viral Disease (2016) (0)
CD8 1 T cells are an in vivo reservoir for human T-cell lymphotropic virus type I (2001) (0)
Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection (2023) (0)
From the Co-Chairs of the 5th International Conference on HHV-6 & 7 (2006) (0)
Novel Retro-inverso Envelope Peptide Mimetic Fusion Inhibitors as a Potential Therapy for HTLV-1 Infected Individuals (2006) (0)
Characterization and Sequencing of a Full-Length Form of HTLV-I from an HTLV-I/II Seroindeterminate Individual (1999) (0)
Quantifying spinal cord cross-sectional area in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2014) (0)
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals (2014) (0)
Transcriptomic architecture of nuclei in the marmoset CNS (2022) (0)
I-Associated Neurological Disease Human T Lymphotropic Virus Type Antigen-Specific T Cells of Patients with An Altered Peptide Ligand Antagonizes (2000) (0)
Virus-induced CXCL10-CXCR3 positive feedback loop via astrocytes is critical for maintaining chronic inflammatory lesions in HAM/TSP (2014) (0)
Droplet digital PCR for the precise quantification of HTLV-1 (2014) (0)
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals (2013) (0)
Detection of human herpesvirus 6 (HHV6) in CNS tumors: A predominance of active viral replication in glial tumors. (2008) (0)
Human T-Cell Lymphotropic Virus Types 1 and 2 (2016) (0)
Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations (2014) (0)
Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells (2023) (0)
Pilot study of Raltegravir, an Integrase inhibitor, in Human T-cell lymphotrophic virus-1 (HTLV-1) associated myelopathy, tropical spastic paraparesis (HAM/TSP). (P6.300) (2015) (0)
Dysregulation of TGF- (cid:1) signaling and regulatory and effector T-cell function in virus-induced neuroinﬂammatory disease (2008) (0)
Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases (2015) (0)
Viral Triggers and Inflammatory Mechanisms in Pediatric Epilepsy (2018) (0)
Limited T cell receptor Vα and Vβ chain usage in HTLV-I specific cytotoxic T lymphocytes in HAM/TSP patients (1994) (0)
Multi-Sequence Serial 7-Tesla MRI in Experimental Autoimmune Encephalomyelitis of the Common Marmoset (S2.005) (2016) (0)
3: Astrocytic HHV-6 infection dysregulates glutamate uptake and expression of glutamate transporters (2006) (0)
Prevalence of Optical Coherence Tomography (OCT) Abnormalities in a Cohort of HLTV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Patients (P4.071) (2015) (0)
Digital droplet PCR for precise quantification of human T-lymphotropic virus 1 proviral loads (2014) (0)
Using a sensitive luciferase immunoprecipitation system (LIPS) to detect HTLV-I/II seroindeterminates in Jamaica (2011) (0)
Concentration Dependent Inhibitory Effect of a Nucleoside-based Analog Against Human Herpesvirus-6 Replication (P6.304) (2015) (0)
Increased coinfection of Human Herpesviruses 6A (HHV-6A) and HHV-6B in Multiple Sclerosis patients (P7.014) (2015) (0)
Impaired measles-specific cytotoxic T-cell response in SSPE (1987) (0)
Deep sequencing of the TCRβ repertoire reveals T cell clonal expansion is associated with HTLV-1 proviral load in HAM/TSP patients (2015) (0)
Brief Definitive Report Identification of a Specific Hla Dr2 Ia Molecule as a Restriction Element for Measles Virus- Specific Hla Class Ii-restricted Cytotoxic T Cell Clones (2003) (0)
17th International Confernce on Human Retroviruses: HTLV and Related Viruses (2015) (0)
Detection of HTLV-I tax Specific T Cells by Soluble Divalent HLA-Ig Fusion Proteins in PBL and CSF of HAM/TSP patients. (1999) (0)
Editorial (2016) (0)
The Role of Extracellular Vesicles (EVs) and EV-cargo in virally-mediated CNS diseases. (1569) (2020) (0)
Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases (2015) (0)
4: Complete replication cycle and acquisition of tegument in nucleus of human herpesvirus 6A (HHV-6A) in astrocytes and in T-cells (2006) (0)
The reverse genetics of HTLV-1 infected patients (2011) (0)
Measles virus-specific cytotoxic T cell responses to purified measles virus antigens (1985) (0)
ORFI genetic polymorphisms in geographically distinct HTLV-1 infections (2015) (0)
Interferon beta induces interferon regulatory factor-2 and inhibits T cell proliferation during infection with HTLV-I (1999) (0)
, P cytotoxic T cells . susceptibility to lysis by CD 8 + HTLV-1-specific induction of tumor necrosis factor alpha and lymphotropic virus type 1 ( HTLV-1 ) Tax : Astrocyte-specific expression of human T-cell (1997) (0)
Epigenetic Modification of the FoxP3 TSDR in HAM/TSP Decreases the Functional Suppression of Tregs (2014) (0)
Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma (2015) (0)
6: Viable HHV-6A viral particles purified with iodixanol gradients (2006) (0)
Chemokines in chronic progressive neurological multiple sclerosis (1999) (0)
Title Detection of HHV-6 and EBV and cytokine levels in saliva from children with seizures : Results of a multi-center cross-sectional study (2018) (0)
T 2 * and phase contrast in marmoset brain (2010) (0)
Deep sequencing of T-cell receptor repertoire reveals enrichment of highly expanded clonotypes in cerebrospinal fluid from multiple sclerosis (2014) (0)
Human T Lymphotropic Virus Type I (Htlv-I)-Specific T Helper Cell Responses from Htlv-I Seronegative Patients with Chronic Myelopathy and Ms in Japan (1996) (0)
HTLV-I Associated Myelopathy Linked to Lower Gray Matter Volume (P6.119) (2016) (0)
Human T-Cell Lymphotropic Viruses (HTLVs) (2014) (0)
Neuroimmunomodulation of Human T-Lymphotrophic Virus Type I/II Infection (2017) (0)
7: Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes (2006) (0)
1395 Automated Lesion Segmentation in a Marmoset Model of Multiple Sclerosis via Subtraction MRI (2013) (0)
Abstract 2526: CP690550 inhibits interleukin-2 (IL-2), IL-9 and IL-15 mediated JAK3 activation and proliferation of T cells obtained from patients with HTLV-1-associated adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2010) (0)
Frontal and Hippocampal Tangles and Plaque Density Are Associated with Anosognosia in Alzheimer Disease (P05.051) (2012) (0)
HTLV-1 Tax induces Th1 master regulator T-bet and thus IFN-γ in CD4+CCR4+ T-cells of virus-associated myelopathy patients (2015) (0)
disease.with HTLV-1-associated neurologic proviral DNA in peripheral blood lymphocytes T-cell lymphotropic virus type 1 (HTLV-1) tax PCR-in situ hybridization detection of human (2013) (0)
HLA Class11-Restricted Presentation ofCytoplasmic MeaslesVirus Antigens toCytotoxic T Cells (1989) (0)
MPA PASS Enables Stitched Multiplex Multi-Dimensional EV Repertoire Analysis (2021) (0)
Astrocyte-Specific Expression of an HTLV-I tax Transgene: A Potential Mouse Model for HAM/TSP (1999) (0)
Multiple sclerosis and HTLV retroviruses (1990) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Steven Jacobson?

Steven Jacobson is affiliated with the following schools:

Steven Jacobson's Academic­Influence.com Rankings

Steven Jacobson's Degrees

Similar Degrees You Can Earn

Why Is Steven Jacobson Influential?

Steven Jacobson's Published Works

Published Works

What Schools Are Affiliated With Steven Jacobson?

Steven Jacobson's AcademicInfluence.com Rankings